1,188 filings
Page 5 of 60
8-K
rhppffh
31 Dec 19
Entry into a Material Definitive Agreement
7:36am
8-K
iupyftzqrh57v8gzxy6
18 Dec 19
VIVUS Announces New Data Supporting the Safety and Efficacy of Qsymia® in Adolescents with Obesity
7:35am
CT ORDER
vr8k1 qdblvgwi
13 Dec 19
Confidential treatment order
4:26pm
8-K
d4p5hx5
20 Nov 19
Other Events
7:35am
4
wi5c72jaw04qwrd6 jfm
18 Nov 19
VIVUS / Mark K Oki ownership change
4:51pm
4
qt2 6x37tc4kfqpp
18 Nov 19
VIVUS / Santosh T Varghese ownership change
4:51pm
CT ORDER
9n506zx6h4n
14 Nov 19
Confidential treatment order
1:28pm
8-K
fa77zvi5toay19k797cp
8 Nov 19
VIVUS, Inc. Q3 2019 Earnings Conference Call
4:11pm
8-K
8wag92f8w6u etn
5 Nov 19
VIVUS Reports Third Quarter 2019 Financial Results
4:10pm
8-K
15dprlru
28 Oct 19
VIVUS Announces Departures of Eric W. Roberts and Allan L. Shaw from Board of Directors
7:35am
8-K
yqelyemog
21 Oct 19
VIVUS to Highlight Integrated Approach to More Effective Weight Management in Panel Discussion at the Cleveland Clinic 2019 Medical Innovation Summit
7:35am
8-K
3fmxocuzn46k7009wkuk
7 Oct 19
VIVUS Announces Acceptance of Qsymia Decentralized Marketing Authorization Application in Europe
7:35am
8-K
hae6ng kx8a8
3 Oct 19
VIVUS Initiates Pay Down of Secured Debt and Announces Management Changes
7:36am
8-K
pzfqum6
5 Sep 19
Regulation FD Disclosure
7:31am
8-K
h7kop0xdb
27 Aug 19
Other Events
7:36am
8-K
20qhfo2386brj7
20 Aug 19
Other Events
7:35am
8-K
gmqq6n7kk4
9 Aug 19
VIVUS, Inc. Q2 2019 Earnings Conference Call
4:05pm
S-8
jyty0t9wpw4u
6 Aug 19
Registration of securities for employees
4:52pm
8-K
qf0r 0t1zcelfbmb1
6 Aug 19
VIVUS Reports Second Quarter 2019 Financial Results
4:10pm